| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 137, 533-539, Copyright © 1996 by Endocrine Society
ARTICLES |
PA Doris, A Hayward-Lester, D Bourne and DM Stocco
Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock 79430, USA.
The adrenal cortex releases a sodium pump inhibitor. The present studies tested whether this material was endogenous and identical to ouabain by 1) studying the production of ouabain in long term cultures of adrenocortical cells, 2) seeking evidence that ouabain might be taken up from exogenous sources by adrenocortical cells, 3) examining the release of adrenocortical cells loaded with exogenous ouabain, 4) attempting to stimulate ouabain steroidogenesis in cultured adrenocortical cells, and 5) performing further chemical analysis on ouabain immunoreactivity released by cultured adrenocortical cells. Our results indicate that ouabain immunoreactivity is present in conditioned medium from both murine Y-1 adrenocortical cultures and primary bovine adrenocortical cell (BAC) cultures. We also found that BACs bind and internalize [3H]ouabain. Bound [3H]ouabain is released from BACs by both receptor dissociation and cytoplasmic release of internalized [3H]ouabain. Only one isoform of membrane sodium, potassium-adenosine triphosphatase, alpha 1, was expressed in the adrenal. Authentic ouabain was not metabolized during membrane binding or while present intracellularly. Stimulation of steroidogenesis in Y-1 and BAC with 22R-hydroxycholesterol and 25-hydroxycholesterol was performed and confirmed increased steroidogenesis; however, there was no effect on ouabain immunoreactivity content or release. Comparison of the ouabain binding density in cultured BAC, hepatoma cells, and 3T3 fibroblasts indicated that adrenocortical cells have a high ouabain- binding capacity. HPLC studies of the ouabain immunoreactivity released by bovine adrenocortical cells indicated that essentially no authentic ouabain was secreted. The present studies confirm that both BAC and Y-1 cultures release a ouabain-like material that differs in structure from authentic plant ouabain and is not a product of cholesterol side-chain cleavage.
This article has been cited by other articles:
![]() |
W. Schoner and G. Scheiner-Bobis Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth Am J Physiol Cell Physiol, August 1, 2007; 293(2): C509 - C536. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yoshika, Y. Komiyama, M. Konishi, T. Akizawa, T. Kobayashi, M. Date, S. Kobatake, M. Masuda, H. Masaki, and H. Takahashi Novel Digitalis-Like Factor, Marinobufotoxin, Isolated From Cultured Y-1 Cells, and Its Hypertensive Effect in Rats Hypertension, January 1, 2007; 49(1): 209 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. El-Masri, B. J. Clark, H. M. Qazzaz, and R. Valdes Jr Human Adrenal Cells in Culture Produce Both Ouabain-like and Dihydroouabain-like Factors Clin. Chem., October 1, 2002; 48(10): 1720 - 1730. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Parhami-Seren, R. Haberly, M. N. Margolies, and G. T. Haupert Jr Ouabain-Binding Protein(s) From Human Plasma Hypertension, August 1, 2002; 40(2): 220 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Ward, B. P. Hamilton, and J. M. Hamlyn Novel Receptors for Ouabain: Studies in Adrenocortical Cells and Membranes Hypertension, February 1, 2002; 39(2): 536 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. I. Dmitrieva, A. Y. Bagrov, E. Lalli, P. Sassone-Corsi, D. M. Stocco, and P. A. Doris Mammalian Bufadienolide Is Synthesized From Cholesterol in the Adrenal Cortex by a Pathway That Is Independent of Cholesterol Side-Chain Cleavage Hypertension, September 1, 2000; 36(3): 442 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Parhami-Seren, C. Bell, M. N. Margolies, and G. T. Haupert Jr. Monoclonal Antibodies That Distinguish Between Two Related Digitalis Glycosides, Ouabain and Digoxin J. Immunol., October 15, 1999; 163(8): 4360 - 4366. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-C. Tsai, C.-C. Lu, J.-J. Chen, Y.-C. Chiao, S.-W. Wang, J.-J. Hwang, and P. S. Wang Inhibition of salmon calcitonin on secretion of progesterone and GnRH-stimulated pituitary luteinizing hormone Am J Physiol Endocrinol Metab, July 1, 1999; 277(1): E49 - E55. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Rabini, P. Fumelli, G. Zolese, E. Amler, E. Salvolini, R. Staffolani, N. Cester, and L. Mazzanti Modifications Induced by Plasma from Insulin-Dependent Diabetic Patients and by Lysophosphatidylcholine on Human Na+,K+-Adenosine Triphosphatase J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2405 - 2410. [Abstract] [Full Text] |
||||
![]() |
C. De Angelis and G. T. Haupert Jr. Hypoxia triggers release of an endogenous inhibitor of Na+-K+-ATPase from midbrain and adrenal Am J Physiol Renal Physiol, January 1, 1998; 274(1): F182 - F188. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Laredo, J. R. Shah, Z.-r. Lu, B. P. Hamilton, and J. M. Hamlyn Angiotensin II Stimulates Secretion of Endogenous Ouabain From Bovine Adrenocortical Cells via Angiotensin Type 2 Receptors Hypertension, January 1, 1997; 29(1): 401 - 407. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |